Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
31.00
+0.75 (2.48%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Arcus Biosciences Employees
Arcus Biosciences had 601 employees as of December 31, 2025. The number of employees decreased by 26 or -4.15% compared to the previous year.
Employees
601
Change (1Y)
-26
Growth (1Y)
-4.15%
Revenue / Employee
$392,679
Profits / Employee
-$613,977
Market Cap
3.90B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Crinetics Pharmaceuticals | 594 |
| Beam Therapeutics | 522 |
| Denali Therapeutics | 507 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Relay Therapeutics | 193 |
RCUS News
- 3 days ago - Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
- 16 days ago - Arcus Biosciences Transcript: AGM 2026 - Transcripts
- 18 days ago - Arcus Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 18 days ago - Arcus Biosciences Slides: FY 2026 - Filings
- 23 days ago - Arcus Biosciences initiated with an Outperform at LifeSci Capital - TheFly
- 24 days ago - Arcus enters clinical trial collaboration, supply agreement with Bristol Myers - TheFly
- 24 days ago - Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer - Business Wire
- 4 weeks ago - Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire